Cognitive functioning and mental health in children with a primary mitochondrial disease
- PMID: 36183138
- PMCID: PMC9526923
- DOI: 10.1186/s13023-022-02510-7
Cognitive functioning and mental health in children with a primary mitochondrial disease
Abstract
Background: Studies regarding cognitive and mental health functioning in children with mitochondrial disease (MD) are scarce, while both are important issues given their impact on QoL. Knowledge on these aspects of functioning and its relationship with disease parameters is essential to gather more insight in working mechanisms and provide recommendations for future research and patientcare. The aim of this study was to map the cognitive functioning and mental health in children with MD in relation to disease specific factors.
Methods: Pediatric patients (< 18 year) with a genetically confirmed MD were included. Demographic and disease specific factors (International Paediatric Mitochondrial Disease Scale) were assessed, as well as cognitive functioning (intelligence, attention, working memory (WM)), and mental health (psychological functioning and quality of life). Individual patient data was described.
Results: Thirty-three children with MD were included. Intellectual functioning ranged from a clinically low IQ (36% of the patients, N = 12/33) to an average or above average IQ (39%, N = 13/33). A higher verbal versus performance IQ was observed (36% N = 5/14), a lower processing speed (43%, N = 6/14), attentional problems (50%, N = 7/14), and verbal WM problems (11%, N = 2/18). Regarding mental health, general behavioral problems were reported (45%, N = 10/22), and on subscale level, attention problems (45%, N = 10), withdrawn/depressed (36%, N = 8/22) and anxious/depressed behavior (14%, N = 3/22). Furthermore, QoL impairments were reported (42%, N = 5/12). The specific intelligence profiles, cognitive impairments, behavioral problems and QoL impairments occurred in every intelligence subgroup. Children with an average or above general intellectual functioning had a generally lower and less variability in IPMDS scores, less frequently epilepsy, vision and hearing problems, and a relatively later age of onset, as compared to patients with a clinically low intellectual functioning.
Conclusions: Despite considerable heterogeneity, overall results showed a high rate of impairments in both cognitive and mental health functioning. Also in children with an average or above level of intellectual functioning, specific cognitive impairments were observed. Children with a clinically low intellectual functioning more often had disease related impairments compared to children with a higher intellectual functioning. The importance of structural assessment of cognitive functioning and mental health is warranted, also in children with mild disease related symptoms.
Keywords: Attention; Cognitive functioning; Disease manifestation; Mental health; Mitochondrial disease; Quality of life; Working memory.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
A conceptual disease model for quality of life in mitochondrial disease.Orphanet J Rare Dis. 2022 Jul 15;17(1):263. doi: 10.1186/s13023-022-02411-9. Orphanet J Rare Dis. 2022. PMID: 35841006 Free PMC article.
-
Cognitive functioning and mental health in mitochondrial disease: A systematic scoping review.Neurosci Biobehav Rev. 2021 Jun;125:57-77. doi: 10.1016/j.neubiorev.2021.02.004. Epub 2021 Feb 11. Neurosci Biobehav Rev. 2021. PMID: 33582231
-
The impact of intelligence on memory and executive functions of children with temporal lobe epilepsy: Methodological concerns with clinical relevance.Eur J Paediatr Neurol. 2017 May;21(3):500-506. doi: 10.1016/j.ejpn.2016.12.010. Epub 2016 Dec 29. Eur J Paediatr Neurol. 2017. PMID: 28089585
-
Detecting epilepsy-related cognitive problems in clinically referred children with epilepsy: is the WISC-IV a useful tool?Epilepsia. 2012 Jun;53(6):1060-6. doi: 10.1111/j.1528-1167.2012.03493.x. Epub 2012 May 3. Epilepsia. 2012. PMID: 22554239
-
Intelligence and specific cognitive functions in intellectual disability: implications for assessment and classification.Curr Opin Psychiatry. 2018 Mar;31(2):88-95. doi: 10.1097/YCO.0000000000000387. Curr Opin Psychiatry. 2018. PMID: 29206685 Review.
Cited by
-
A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.Clin Cancer Res. 2024 Dec 2;30(23):5399-5412. doi: 10.1158/1078-0432.CCR-24-1601. Clin Cancer Res. 2024. PMID: 39321216 Free PMC article.
-
Puerarin improves the comorbidity of chronic pain and depression by binding with Bax and reducing mitochondrial dysfunction.Mol Pain. 2025 Jan-Dec;21:17448069251335230. doi: 10.1177/17448069251335230. Epub 2025 Apr 4. Mol Pain. 2025. PMID: 40183499 Free PMC article.
References
-
- Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms & profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2000.
-
- Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2001.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical